Showing results (1-10 of 823) with videos related to
Sort By:
Pageof 83
Clinical Microbiology Reviews|October 1, 1993
Antifungal susceptibility testingJ H Rex, M A Pfaller, M G Rinaldi, et al.Infectious Disease Clinics of North America|June 1, 1993
Antifungal susceptibility testing. Current state of technology, limitations, and standardizationM A Pfaller, M G RinaldiClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1997
Antifungal susceptibility testing: technical advances and potential clinical applicationsM A Pfaller, J H Rex, M G RinaldiJournal of Clinical Microbiology|December 11, 1992
Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility testsA Espinel-Ingroff, C W Kish, T M Kerkering, et al.Journal of Clinical Microbiology|August 1, 1988
Multicenter evaluation of four methods of yeast inoculum preparationM A Pfaller, L Burmeister, M S Bartlett, et al.Antimicrobial Agents and Chemotherapy|September 1, 1990
Collaborative investigation of variables in susceptibility testing of yeastsM A Pfaller, M G Rinaldi, J N Galgiani, et al.Journal of Clinical Microbiology|January 12, 2007
Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida sppM A Pfaller, D J Diekema, G W Procop, et al.Antimicrobial Agents and Chemotherapy|October 1, 1996
Microdilution antifungal susceptibility testing of Candida albicans and Cryptococcus neoformans with and without agitation: an eight-center collaborative studyE J Anaissie, V L Paetznick, L G Ensign, et al.Journal of Clinical Microbiology|October 5, 2007
Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida sppM A Pfaller, D J Diekema, G W Procop, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1997
Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory StandardsJ H Rex, M A Pfaller, J N Galgiani, et al.Pageof 83